ArticleBone & joint open2025
The use of porous titanium acetabular augments in primary total hip arthroplasty for hip dysplasia or rapidly destructive coxopathy.
Article in Bone & joint open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Japan's contributions to hip joint preservation and reconstruction: from osteonecrosis and developmental dysplasia to precision arthroplasty.International orthopaedics · 2026Review
- THA for DDH: replacement principles and techniques - acetabular side.EFORT open reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study aimed to evaluate the efficacy of porous titanium acetabular augments in primary total hip arthroplasty (THA) for reconstruction of superolateral acetabular bone defects in patients with Crowe II or higher classes of developmental dysplasia of the hip (DDH) or rapidly destructive coxopathy (RDC). Methods: We conducted a retrospective evaluation of 27 patients (30 hips) who underwent primary THA using cementless cups and porous titanium acetabular augments. The follow-up periods ranged from two to 11 years, with a mean of 5.0 years. The cohort included 22 females (24 hips) and five males (six hips), with a mean age of 67 years (45 to 83) at the time of surgery. Results: At the final follow-up, there was no radiological evidence of loosening or radiolucency around the cups and augments, indicating successful biological fixation in all cases. Clinically, there was a significant improvement in the Western Ontario and McMaster Universities Osteoarthritis Index score, which improved from a mean of 39.1 (SD 14.7) preoperatively to 5.1 (SD 6.4) postoperatively. Conclusion: The use of cementless cups and porous acetabular titanium augments in primary THA for patients with DDH and RDC can lead to considerable clinical improvements and reliable biological fixation, suggesting their potential as a viable solution for managing challenging acetabular defects in these conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.